Orgovyx
NDC 72974-120 · Sumitomo Pharma America, Inc.
Generic namerelugolix
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)RELUGOLIX
Strength120 mg/1
Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing categoryNDA
Packages
72974-120-01 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)
72974-120-95 — 16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)
72974-120-97 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
72974-415 — relugolix, estradiol hemihydrate, and norethindrone acetate